Clinical Insights

Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, FAAN, provides clinicians with practical psychoeducation strategies to strengthen attention-deficit/hyperactivity disorder (ADHD) management.

Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.

Hara Oyedeji, DNP, PMHNP-BC, MSEd, provides an overview of the relationship between sleep-wake disruptions and major depressive disorder (MDD).

Taylor Crews, PMHNP-BC, explores how clinicians can navigate conversations with patients who suspect they may have attention-deficit/hyperactivity disorder (ADHD) based on information from social media.

Kevin Williams, MS, MPAS, PA-C, walks clinicians through his patient-centered approach to finding the most appropriate adjunctive treatment option for major depressive disorder.

Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.

Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discusses how clinicians can support patients through the early stages of treatment for major depressive disorder.

Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares several communication strategies to effectively address patient concerns when considering augmentation for major depressive disorder (MDD).

Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, FAAN, explains key differences in stimulant and non-stimulant treatment options for ADHD.